McKinsey May, 2018
Olivia Cavlan, Sastry Chilukuri, Matthias Evers, and Ann Westra

While there is general agreement that real-world evidence could significantly improve how healthcare stakeholders make decisions, expanding its use requires action by multiple stakeholders.

Healthcare is rapidly transitioning to a new world of patient choice with a laser-like focus on outcomes and value. Indeed, healthcare systems that have traditionally focused on medical interventions driven via episodic interaction with the patient are now recognizing the need to fully understand exogenous factors and deliver continual care.

Exogenous factors such as genomics, behavior, and social and environmental influences play a critical role in delivering outcomes and value for patients and health systems; meanwhile, technology is finally allowing the capture and analysis of such real-world data (Exhibit 1).

Researchers...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Big Data, CMS, Employer, EMR / EHR, Govt Agencies, Health System / Hospital, Healthcare System, HHS, Insurance, Medicaid, Medicare, Payer, Pharma, Physician, Provider, Technology, Trends
The Ripple Effect: Ways to Make Health in All Policies Stick in Kansas and Beyond to Enhance Health and Equity
Katie Couric Talks Colon Cancer, Health Equity And AI
Ernst & Young: Health equity efforts maturing, but data capabilities remain barrier
Research Funding Is Needed To Support An Effective, Equitable, And Sustainable Public Health System
Covid’s scientific silver lining: A chance to watch the human immune system respond in real time

Share This Article